Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies
Trial details
- Registry ID
- NCT02214160
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as C7; Triheptanoin
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin StudiesNCT02214160 | RARE | Phase 2 | Completed | 2020-12-03Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |